Med BioGene Appoints Geneticist Michael R. Hayden as Director
Med BioGene Inc is pleased to announce that Michael R. Hayden, MD, PhD, FRCPC, has joined the company’s Board of Directors.
Read MoreSearch Results for: lung cancer
The Need for Molecular Diagnostics
The need for quick H1N1 assays further propels molecular to the forefront.
Read MoreClarient Acquires Applied Genomics
Clarient Inc has announced that it has acquired privately held, Huntsville, Ala-based Applied Genomics Inc (AGI) in an all-stock merger valued at up to $17.6 million.
Read MoreClarient, BioView Work to Finalize Lung Cancer Molecular Diagnostic Test
Clarient Inc, a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, and BioView Ltd jointly announced that they will collaborate on studies to validate the clinical utility of a non-invasive test for the early detection of non-small cell lung cancer.
Read MoreBiomoda, Christiana Care Partner to Complete Pilot Study on Cancer Diagnostic
The Helen F. Graham Cancer Center associated with Christiana Care Health System will recruit a cohort of patients diagnosed with lung cancer to participate in the final stage of the Phase II pilot study of the investigational CyPath assay, an early-stage diagnostic test for lung cancer.
Read More